API CAS 486460 -32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

China API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin, Find details about China Sitagliptin, Sitagliptin Powder from API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

Basic Info.

Model NO.

Condavo-Sitagliptin

Name

Sitagliptin

Product Name

Sitagliptin Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

CAS

486460-32-6

C16h15f6n5o

407.31400

Density

1.614G/Cm3

Boiling Point

529.905c at 760 Mmhg

Refractive Index

1.59

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Sitagliptin

Name

Sitagliptin

Product Name

Sitagliptin Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

CAS

486460-32-6

C16h15f6n5o

407.31400

Density

1.614G/Cm3

Boiling Point

529.905c at 760 Mmhg

Refractive Index

1.59

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

Product Name	Sitagliptin
CAS	486460-32-6
Appearance	White crystalline powder
MF	C16H15F6N5O
MW	407.31400
Purity	99%
Shelf Life	2 Years

Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug for the treatment of type II diabetes. Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs. It improves the ability of diabetic patients' own pancreatic β cells to produce Chemicalbook and increases the secretion of when blood sugar rises, thereby controlling the blood sugar level of diabetic patients. Clinical studies have shown that sitagliptin is an oral effective drug with good market prospects. It has a significant hypoglycemic effect when used alone or in combination with metformin and pioglitazone, and it is safe to take, well tolerated, and has fewer adverse reactions.

API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin Treating type 2 diabetes in patients who cannot control blood sugar levels by diet and exercise alone. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.Sitagliptin is a dipeptidyl peptidase4 (DPP4) inhibitor. It works by increasing the amount of insulin released by your body and decreasing the amount of sugar made by your body.
API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin

Sitagliptin is an oral antihyperglycemic of the dipeptidyl peptidase-4 inhibitor class. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents for treatment of diabetes mellitus type 2.The benefit of this medicine is its fewer side effects in the control of blood glucose values. While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents such as metformin.

API CAS 486460-32-6 Sitagliptin Material Sitagliptin Intermediate Sitagliptin